Resolute Bio was founded as OmicVision Biosciences in late 2023. Our roots are in Deep Visual Proteomics, a technology platform invented and co-developed by Resolute co-founder Dr. Andreas Mund.
Deep Visual Proteomics has been cited by hundreds of research groups across the world, and is widely credited as the first spatial-omics technology to have direct impact on patient care.
Read more here.
Since, Resolute Bio has engineered Deep Visual Proteomics into an intelligent, high-throughput platform to create a new dimension of biological discovery and understanding.
By studying proteins in an unbiased manner, in their native human tissue context, we can redefine our understanding of disease and ultimately, approach to treatment.
We call this Spatial Medicine.












